• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西班牙苯丙氨酸羟化酶缺乏症的遗传和表型特征:按地区进行的分子调查

Genetic and phenotypic aspects of phenylalanine hydroxylase deficiency in Spain: molecular survey by regions.

作者信息

Desviat L R, Pérez B, Gámez A, Sánchez A, García M J, Martínez-Pardo M, Marchante C, Bóveda D, Baldellou A, Arena J, Sanjurjo P, Fernández A, Cabello M L, Ugarte M

机构信息

Centro de Biología Molecular Severo Ochoa CSIC-UAM, Universidad Autónoma, Madrid, Spain.

出版信息

Eur J Hum Genet. 1999 Apr;7(3):386-92. doi: 10.1038/sj.ejhg.5200312.

DOI:10.1038/sj.ejhg.5200312
PMID:10234516
Abstract

We present an extensive study of the genetic diversity of phenylalanine hydroxylase deficiency in the Spanish phenylketonuria population. We have analysed 195 PKU patients by DGGE analysis identifying 67 different mutations which represent 89% of the total mutant chromosomes. Seventeen mutations first described in Spain have not yet been detected elsewhere; ten of these are reported here for the first time. The clinical significance of this high genetic heterogeneity was examined by analysing the genotype-phenotype correlations, mainly focusing on the mild hyperphenylalaninaemia (MHP) phenotype. The genotypes found in a group of 93 MHP patients, the largest analysed so far, are described in detail, as well as the relative frequencies of the MHP mutations identified. From the total pool of mutations, 27 can be considered severe, 18 can be defined as mild and 13 as associated with MHP. The prevalent mutations correspond to one severe mutation (IVS10nt-11), one MHP mutation (A403V) and two mild mutations (165T and V388M). The high frequency of mutations with a low degree of severity can explain the relatively higher prevalence of MHP and mild PKU phenotypes in Spain compared with NOrthern European populations. We have looked at the geographical distribution in Spain of the more common mutations, finding evidence of local mutation clustering, which could be the result of differences in the ethnic background and/or of genetic drift within each region.

摘要

我们对西班牙苯丙酮尿症患者群体中苯丙氨酸羟化酶缺乏症的基因多样性进行了广泛研究。我们通过变性梯度凝胶电泳(DGGE)分析了195例苯丙酮尿症患者,鉴定出67种不同突变,这些突变占突变染色体总数的89%。17种首次在西班牙发现的突变在其他地方尚未被检测到;其中10种在此首次报道。通过分析基因型与表型的相关性,主要关注轻度高苯丙氨酸血症(MHP)表型,研究了这种高度基因异质性的临床意义。详细描述了在一组93例MHP患者(迄今为止分析的最大群体)中发现的基因型,以及所鉴定的MHP突变的相对频率。在所有突变中,27种可被视为严重突变,18种可定义为轻度突变,13种与MHP相关。常见突变包括一种严重突变(IVS10nt-11)、一种MHP突变(A403V)和两种轻度突变(165T和V388M)。与北欧人群相比,低严重程度突变的高频率可以解释西班牙MHP和轻度苯丙酮尿症表型相对较高的患病率。我们研究了西班牙较常见突变的地理分布,发现了局部突变聚集的证据,这可能是由于各地区种族背景差异和/或基因漂变所致。

相似文献

1
Genetic and phenotypic aspects of phenylalanine hydroxylase deficiency in Spain: molecular survey by regions.西班牙苯丙氨酸羟化酶缺乏症的遗传和表型特征:按地区进行的分子调查
Eur J Hum Genet. 1999 Apr;7(3):386-92. doi: 10.1038/sj.ejhg.5200312.
2
Validation of PAH genotype-based predictions of metabolic phenylalanine hydroxylase deficiency phenotype: investigation of PKU/MHP patients from Lithuania.基于苯丙酮尿症(PAH)基因型预测代谢性苯丙氨酸羟化酶缺乏表型的验证:立陶宛苯丙酮尿症/轻度高苯丙氨酸血症(PKU/MHP)患者的调查
Med Sci Monit. 2003 Mar;9(3):CR142-6.
3
Mutation analysis of phenylketonuria patients from Morocco: high prevalence of mutation G352fsdelG and detection of a novel mutation p.K85X.摩洛哥苯丙酮尿症患者的突变分析:突变 G352fsdelG 高发及新型突变 p.K85X 的检测。
Clin Biochem. 2010 Jan;43(1-2):76-81. doi: 10.1016/j.clinbiochem.2009.09.018. Epub 2009 Sep 26.
4
Relationship between mutation genotype and biochemical phenotype in a heterogeneous Spanish phenylketonuria population.西班牙苯丙酮尿症异质群体中突变基因型与生化表型的关系。
Eur J Hum Genet. 1997 Jul-Aug;5(4):196-202.
5
Molecular characterization of phenylalanine hydroxylase deficiency in Chile. Mutations in brief no. 243. Online.智利苯丙氨酸羟化酶缺乏症的分子特征。简讯中的突变第243号。在线版。
Hum Mutat. 1999;13(6):503. doi: 10.1002/(SICI)1098-1004(1999)13:6<503::AID-HUMU12>3.0.CO;2-I.
6
Phenylketonuria mutations in Northern China.中国北方的苯丙酮尿症突变
Mol Genet Metab. 2005 Dec;86 Suppl 1:S107-18. doi: 10.1016/j.ymgme.2005.09.001. Epub 2005 Oct 26.
7
Molecular basis of phenylketonuria in Cuba.古巴苯丙酮尿症的分子基础。
Hum Mutat. 2001 Sep;18(3):252. doi: 10.1002/humu.1183.
8
Mutations of the phenylalanine hydroxylase (PAH) gene in Brazilian patients with phenylketonuria.巴西苯丙酮尿症患者苯丙氨酸羟化酶(PAH)基因突变情况
Hum Mutat. 2001 Feb;17(2):122-30. doi: 10.1002/1098-1004(200102)17:2<122::AID-HUMU4>3.0.CO;2-C.
9
Predicting a clinical/biochemical phenotype for PKU/MHP patients with PAH gene mutations.预测携带PAH基因突变的苯丙酮尿症/轻度高苯丙氨酸血症患者的临床/生化表型。
Genetika. 2008 Oct;44(10):1397-403.
10
Variations in genotype-phenotype correlations in phenylketonuria patients.苯丙酮尿症患者基因型-表型相关性的变异
Genet Mol Res. 2010 Jan 5;9(1):1-8. doi: 10.4238/vol9-1gmr670.

引用本文的文献

1
Improved specificity and efficacy of base-editing therapies with hybrid guide RNAs.使用杂交引导RNA提高碱基编辑疗法的特异性和疗效。
bioRxiv. 2024 Jun 16:2024.04.22.590531. doi: 10.1101/2024.04.22.590531.
2
A base editing strategy using mRNA-LNPs for in vivo correction of the most frequent phenylketonuria variant.使用 mRNA-LNPs 的碱基编辑策略对最常见的苯丙酮尿症变体进行体内校正。
HGG Adv. 2024 Jan 11;5(1):100253. doi: 10.1016/j.xhgg.2023.100253. Epub 2023 Nov 2.
3
Mutational landscape of phenylketonuria in Iran.伊朗苯丙酮尿症的突变景观。
J Cell Mol Med. 2023 Sep;27(17):2457-2466. doi: 10.1111/jcmm.17865. Epub 2023 Jul 31.
4
Molecular characterization of phenylketonuria patients from the North Region of Brazil: State of Pará.巴西北部地区苯丙酮尿症患者的分子特征:帕拉州。
Mol Genet Genomic Med. 2023 Oct;11(10):e2224. doi: 10.1002/mgg3.2224. Epub 2023 Jul 8.
5
Phenylketonuria.苯丙酮尿症。
Nat Rev Dis Primers. 2021 May 20;7(1):36. doi: 10.1038/s41572-021-00267-0.
6
Molecular characterization of Thai patients with phenylalanine hydroxylase deficiency and in vitro functional study of two novel PAH variants.泰国苯丙氨酸羟化酶缺乏症患者的分子特征及两种新型 PAH 变异体的体外功能研究。
Mol Biol Rep. 2021 Mar;48(3):2063-2070. doi: 10.1007/s11033-021-06163-w. Epub 2021 Mar 7.
7
Spectrum of PAH gene mutations in 1547 phenylketonuria patients from Iran: a comprehensive systematic review.伊朗 1547 例苯丙酮尿症患者的 PAH 基因突变谱:一项全面的系统评价。
Metab Brain Dis. 2021 Jun;36(5):767-780. doi: 10.1007/s11011-021-00698-4. Epub 2021 Feb 24.
8
Phenylketonuria in Portugal: Genotype-phenotype correlations using molecular, biochemical, and haplotypic analyses.葡萄牙苯丙酮尿症:基于分子、生化和单体型分析的基因型-表型相关性。
Mol Genet Genomic Med. 2021 Mar;9(3):e1559. doi: 10.1002/mgg3.1559. Epub 2021 Jan 19.
9
A view on clinical genetics and genomics in Spain: of challenges and opportunities.西班牙临床遗传学与基因组学之展望:挑战与机遇并存
Mol Genet Genomic Med. 2016 Jul 18;4(4):376-91. doi: 10.1002/mgg3.232. eCollection 2016 Jul.
10
Molecular epidemiology, genotype-phenotype correlation and BH4 responsiveness in Spanish patients with phenylketonuria.西班牙苯丙酮尿症患者的分子流行病学、基因型-表型相关性及四氢生物蝶呤反应性
J Hum Genet. 2016 Aug;61(8):731-44. doi: 10.1038/jhg.2016.38. Epub 2016 Apr 28.